Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Nov 22;10(22):5462.
doi: 10.3390/jcm10225462.

Effect of Violet Light-Transmitting Eyeglasses on Axial Elongation in Myopic Children: A Randomized Controlled Trial

Affiliations

Effect of Violet Light-Transmitting Eyeglasses on Axial Elongation in Myopic Children: A Randomized Controlled Trial

Kiwako Mori et al. J Clin Med. .

Abstract

The fact that outdoor light environment is an important suppressive factor against myopia led us to invent violet light-transmitting eyeglasses (VL glasses) which can transmit violet light (VL), 360-400 nm in wavelength, for the suppression of myopia, and can meanwhile block harmful ultraviolet waves from sunlight. The current study is a double-blinded randomized clinical trial to investigate the myopia-suppressive effect of VL glasses compared to conventional eyeglasses (placebo glasses) that do not transmit VL. The subjects were children aged from 6 to 12 years old, the population in which myopia progression is generally accelerated, and the myopia suppressive effect was followed up for two years in a city in Japan. Periodical ophthalmic examinations, interviews, and measurements of reflection and axial length under mydriasis were performed at the initial visit (the baseline) and at 1, 6, 12, 18, and 24 months. The mean change in axial length in the VL glasses group was significantly smaller than in the placebo glasses group when time for near-work was less than 180 min and when the subjects were limited to those who had never used eyeglasses before this trial (p < 0.01); however, this change was not significant without subgrouping. The suppressive rate for axial elongation in the VL glasses group was 21.4% for two years.

Keywords: axial length; double blinded randomized controlled trial; eyeglasses; myopia; myopia control; refraction; violet light.

PubMed Disclaimer

Conflict of interest statement

Tsubota laboratory, Inc., for which Kazuo Tsubota works as the Chief Executive Officer (CEO), receives distribution royalty fees for selling the lenses used in this study from JINS HOLDINGS, Inc., a sponsor of this research.

Figures

Figure 1
Figure 1
Flowchart of the double-blind randomized clinical trial time points and number of participants. Details of the reasons for withdrawal and protocol deviation are described in Table S1. FAS: full analysis set; PPS: per protocol set.
Figure 2
Figure 2
Characteristics of the eyeglasses used in this study: the transmission rate (%) at each wavelength of the light with VL glasses (blue) and with placebo glasses (orange) is shown. VL glasses transmit light 360–400 nm in wavelength, whereas placebo glasses block the light of the wavelengths less than 400 nm.
Figure 3
Figure 3
Time course of the adjusted mean axial elongation and SER change under the limited condition in which near-work time was less than 180 min and there was no previous history of eyeglasses use. (A) change in AL after wearing the eyeglasses, (B) change in SER after wearing the eyeglasses. AL: axial length, SER: spherical equivalent refraction ** p < 0.01.

References

    1. Enthoven C.A., Tidessman J.W.L., Polling J.R., Tedja M.S., Raat H., Iglesias A.I., Verhoeven V.J.M., Klaver C.C.W. Interaction between lifestyle and genetic susceptibility in myopia: The Generation R study. Eur. J. Epidemiol. 2019;34:777–784. - PMC - PubMed
    1. Holden B.A., Jong M., Davis S., Wilson D., Fricke T., Resnikoff S. Nearly 1 billion myopes at risk of myopia-related sight-threatening conditions by 2050–time to act now. Clin. Exp. Optom. 2015;98:491–493. doi: 10.1111/cxo.12339. - DOI - PubMed
    1. Bikbov M.M., Gilmanshin T.R., Kazakbaeva G.M., Zainullin R.M., Rakhimova E.M., Rusakova I.A., Bolshakova N.I., Safiullina K.R., Zaynetdinov A.F., Zinatullin A.A., et al. Prevalence of Myopic Maculopathy Among Adults in a Russian Population. JAMA Netw. Open. 2020;3:e200567. doi: 10.1001/jamanetworkopen.2020.0567. - DOI - PMC - PubMed
    1. Bikbov M.M., Kazakbaeva G.M., Rakhimova E.M., Rusakova I.A., Fakhretdinova A.A., Tuliakova A.M., Panda-Jonas S., Gilmanshin T.R., Zainullin R.M., Bolshakova N.I., et al. Prevalence Factors Associated With Vision Impairment and Blindness Among Individuals 85 Years and Older in Russia. JAMA Netw. Open. 2021;4:e2121138. doi: 10.1001/jamanetworkopen.2021.21138. - DOI - PMC - PubMed
    1. Iwase A., Araie M., Tomidokoro A., Yamamoto T., Shimizu H., Kitazawa Y. Prevalence and causes of low vision and blindness in a Japanese adult population: The Tajimi Study. Ophthalmology. 2006;113:1354–1362. doi: 10.1016/j.ophtha.2006.04.022. - DOI - PubMed

LinkOut - more resources